CEO Rob Hutchison discusses Target Therapeutic Are
Post# of 11
Everett Jolly Interviews Rob Hutchison, CEO for biOasis Technologies Inc. (OTC: BIOAF / TSX-V: BTI) , and they discuss target therapeutic areas of focus for the company.
Listen here for the full interview: http://upticknewswire.com/ceo-rob-hutchison-d...hnologies/